| |
| |
|
| Insider
Information: |
Nodelman Oleg |
| Relationship: |
Director, 10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
50,000 |
|
|
Indirect Shares
|
18,524,214 |
|
|
| Direct
Value |
$462,500 |
|
|
|
Indirect Value
|
$403,299,752 |
|
|
| Total
Shares |
18,574,214 |
|
|
| Total
Value |
$403,762,252 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
1
|
|
Stock
price went up :
|
7
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
1.0
|
| Percentage
Gain/Loss : |
 33.4%
|
11.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genvec Inc |
GNVC |
10% Owner |
|
0 |
2014-05-27 |
962,055 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2014-09-29 |
50,000 |
2014-09-29 |
614,495 |
Premium* |
|
|
Prothena Corp Plc |
PRTA |
Director, 10% Owner |
|
0 |
2019-12-03 |
9,426,640 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
Director, 10% Owner |
|
0 |
2022-05-05 |
7,521,024 |
Premium* |
|
|
Panacea Acquisition Corp. Ii |
PANA |
Director, 10% Owner |
2023-04-28 |
0 |
2023-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PANA |
Panacea Acquisition Corp.... |
Director |
– • • |
2023-04-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(545,000) |
0 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2022-05-05 |
4 |
S |
$21.63 |
$14,453,966 |
I/I |
(668,237) |
7,521,024 |
0 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2022-05-05 |
4 |
B |
$21.63 |
$14,453,966 |
I/I |
668,237 |
7,521,024 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-05-04 |
4 |
B |
$23.25 |
$3,835,755 |
I/I |
165,000 |
7,520,424 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-05-03 |
4 |
B |
$23.31 |
$484,873 |
I/I |
20,800 |
7,355,424 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-04-30 |
4 |
B |
$23.16 |
$826,816 |
I/I |
35,700 |
7,334,624 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-04-27 |
4 |
B |
$23.82 |
$805,089 |
I/I |
33,800 |
7,298,924 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-04-26 |
4 |
B |
$23.80 |
$330,859 |
I/I |
13,900 |
7,265,124 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-04-23 |
4 |
B |
$23.54 |
$2,344,285 |
I/I |
99,600 |
7,251,224 |
2.25 |
% |
|
| ANAB |
Anaptysbio Inc |
Director |
– • • |
2021-04-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,151,624 |
|
% |
|
| PRTA |
Prothena Corp Plc |
Director |
– • • |
2019-12-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,426,640 |
|
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2014-09-29 |
4 |
B |
$9.56 |
$955,970 |
I/I |
100,000 |
614,495 |
2.1 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2014-08-28 |
4 |
B |
$10.98 |
$274,505 |
I/I |
25,000 |
551,793 |
2.1 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2014-08-27 |
4 |
B |
$10.70 |
$235,431 |
I/I |
22,000 |
538,073 |
2.1 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2014-08-26 |
4 |
B |
$10.51 |
$361,034 |
I/I |
34,344 |
517,323 |
2.1 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2014-08-25 |
4 |
B |
$10.49 |
$534,058 |
I/I |
50,900 |
498,476 |
2.1 |
- |
|
| GNVC |
Genvec Inc |
10% Owner |
– – • |
2014-05-27 |
4 |
B |
$2.39 |
$21,620 |
I/I |
9,040 |
962,055 |
1.5 |
- |
|
| GNVC |
Genvec Inc |
10% Owner |
– – • |
2014-05-23 |
4 |
B |
$2.19 |
$10,095 |
I/I |
4,600 |
957,677 |
1.5 |
- |
|
| GNVC |
Genvec Inc |
10% Owner |
– – • |
2014-05-22 |
4 |
B |
$2.13 |
$22,367 |
I/I |
10,500 |
955,449 |
1.5 |
- |
|
| GNVC |
Genvec Inc |
10% Owner |
– – • |
2014-03-28 |
4 |
B |
$2.73 |
$129,849 |
I/I |
47,515 |
785,366 |
1.5 |
- |
|
| GNVC |
Genvec Inc |
10% Owner |
– – • |
2014-03-27 |
4 |
B |
$2.49 |
$127,643 |
I/I |
51,215 |
766,360 |
1.5 |
- |
|
| GNVC |
Genvec Inc |
10% Owner |
– – • |
2014-03-26 |
4 |
B |
$2.31 |
$54,490 |
I/I |
23,543 |
745,874 |
1.5 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2013-12-12 |
4 |
B |
$7.00 |
$2,800,000 |
I/I |
400,000 |
873,187 |
2.1 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2013-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
473,187 |
|
- |
|
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2013-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
